Shalom, welcome to our little world

GlaxoSmithKline is preparing to sell billions worth of swine flu drugs this year. Their swine flu vaccine will be available by September, and international governments are already stockpiling large supplies of GSK's anti-viral treatment Relenza.

Worldwide sales from the two drugs are expected to be enormous, but the company rejected claims it was exploiting the pandemic.

GlaxoSmithKline has also developed an anti-viral face mask, which is expected to be used by people such as "front line health workers."

Sources:



The Guardian July 22, 2009




Regina's Blog July 19, 2009




Click On Detroit July 17, 2009

http://articles.mercola.com/sites/articles/archive/2009/08/13/Swine-Flu-Vaccine-Makers-to-Profit-50-Billion-a-Year.aspx